MTT cell viability assays showed that low-dose JNKi (0.5 μM) alone and low-dose TRAIL (10 ng/mL) alone exerted only a modest effect on cell viability in parental pancreatic cancer cells (Figure 3B). Here, TNFSF10 is linked to familial pancreatic carcinoma.